Chronic Myelomonocytic Leukemia Recruiting Phase 2 Trials for Carboplatin (DB00958)

Also known as: Chronic myelomonocytic leukaemia / Chronic myelomonocytic leukemia with failed remission / Leukemia, Myelomonocytic, Chronic

IndicationStatusPhase
DBCOND0028572 (Chronic Myelomonocytic Leukemia)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03289910Topotecan Hydrochloride and Carboplatin With or Without Veliparib in Treating Advanced Myeloproliferative Disorders and Acute Myeloid Leukemia or Chronic Myelomonocytic LeukemiaTreatment
NCT02190695Leukemia SPORE Phase II 3-arm DAC Randomized Study for R/R and Elderly Acute AML and MDSTreatment